Circulating biomarkers of collagen type i metabolism mark the right ventricular fibrosis and adverse markers of clinical outcome in adults with repaired tetralogy of Fallot

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2963-2968

  Chen, Chun An ^a,b   Tseng, Wen Yih Isaac ^a,b   Wang, Jou Kou ^a   Chen, Ssu Yuan ^a   Ni, Yen Hsuan ^a   Huang, Kuo Chin ^a   Ho, Yi Lwun ^a,b   Chang, Chung I ^a   Chiu, Ing Sh ^a   Su, Mao Yuan Marine ^a   Yu, Hsi Yu ^a   Lin, Ming Tai ^a   Lu, Chun Wei ^a   Wu, Mei Hwan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cardiac fibrosis; Collagen; Magnetic resonance imaging; Tetralogy of Fallot

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; COLLAGEN TYPE 1; GADOLINIUM PENTETATE; MATRIX METALLOPROTEINASE; PROCOLLAGEN TYPE I CARBOXY TERMINAL PROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FALLOT TETRALOGY; FEMALE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FIBROSIS; HEART RIGHT VENTRICLE VOLUME; HEART SURGERY; HEART VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN METABOLISM; SCORING SYSTEM;

CARDIAC FIBROSIS; COLLAGEN; MAGNETIC RESONANCE IMAGING; TETRALOGY OF FALLOT;

ADULT; BIOLOGICAL MARKERS; COLLAGEN TYPE I; FEMALE; FIBROSIS; HEART VENTRICLES; HUMANS; MALE; TETRALOGY OF FALLOT; VENTRICULAR DYSFUNCTION, RIGHT; YOUNG ADULT;

EID: 84883745244     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.08.059     Document Type: Article

References (29)

1. N. Mewton, C.Y. Liu, P. Croisille, D. Bluemke, and J.A. Lima Assessment of myocardial fibrosis with cardiovascular magnetic resonance J Am Coll Cardiol 57 2011 891 903
2. S.V. Babu-Narayan, P.J. Kilner, and W. Li Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome Circulation 113 2006 405 413
3. R.M. Wald, I. Haber, R. Wald, A.M. Valente, A.J. Powell, and T. Geva Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot Circulation 119 2009 1370 1377
4. R. Querejeta, B. Lopez, and A. Gonzalez Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis Circulation 110 2004 1263 1268
5. H. Izawa, T. Murohara, and K. Nagata Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study Circulation 112 2005 2940 2945
6. J. Radovan, P. Vaclav, and W. Petr Changes of collagen metabolism predict the left ventricular remodeling after myocardial infarction Mol Cell Biochem 293 2006 71 78
7. C.Y. Ho, B. Lopez, and O.R. Coelho-Filho Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy N Engl J Med 363 2010 552 563
8. J.M. Tolosana, L. Mont, and M. Sitges Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy Eur J Heart Fail 12 2010 492 498
9. S.A. Rebergen, J.G. Chin, J. Ottenkamp, E.E. van der Wall, and A. de Roos Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping Circulation 88 1993 2257 2266
10. M.D. Cerqueira, N.J. Weissman, and V. Dilsizian Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
11. K. Niwa, S.C. Siu, G.D. Webb, and M.A. Gatzoulis Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot Circulation 106 2002 1374 1378
12. E.R. Buechel, H.H. Dave, and C.J. Kellenberger Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance Eur Heart J 26 2005 2721 2727
13. T. Geva Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support J Cardiovasc Magn Reson 13 2011 9
14. T. Geva, K. Gauvreau, and A.J. Powell Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery Circulation 122 2010 S201 S208
15. R Development Core Team R: A language and environment for statistical computing 2006 R Foundation for Statistical Computing Vienna, Austria Available at: http://www.R-project.org
16. B. Lopez, R. Querejeta, A. Gonzalez, E. Sanchez, M. Larman, and J. Diez Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure J Am Coll Cardiol 43 2004 2028 2035
17. J.C. Moon, E. Reed, and M.N. Sheppard The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264
18. L. Iles, H. Pfluger, and A. Phrommintikul Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 2008 1574 1580
19. C.S. Broberg, S.S. Chugh, C. Conklin, D.J. Sahn, and M. Jerosch-Herold Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease Circ Cardiovasc Imaging 3 2010 727 734
20. S.H. Ahmed, L.L. Clark, and W.R. Pennington Matrix metalloproteinases/ tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease Circulation 113 2006 2089 2096
21. J.L. Tan, P.A. Davlouros, K.P. McCarthy, M.A. Gatzoulis, and S.Y. Ho Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot: evidence of causative mechanism for aortic dilatation and aortopathy Circulation 112 2005 961 968
22. J.S. Ikonomidis, J.A. Jones, and J.R. Barbour Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome Circulation 114 2006 I365 I370
23. P.A. Davlouros, P.J. Kilner, and T.S. Hornung Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction J Am Coll Cardiol 40 2002 2044 2052
24. J. Melkko, S. Niemi, L. Risteli, and J. Risteli Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen Clin Chem 36 1990 1328 1332
25. A. Piovesan, A. Berruti, and G. Osella Serum levels of carboxyterminal propeptide of type I procollagen in cancer patients with osteoblastic and osteolytic bone metastases Int J Biol Markers 9 1994 243 246
26. B. Bouzas, P.J. Kilner, and M.A. Gatzoulis Pulmonary regurgitation: not a benign lesion Eur Heart J 26 2005 433 439
27. A.L. Knauth, K. Gauvreau, and A.J. Powell Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair Heart 94 2008 211 216
28. F. Zannad, F. Alla, B. Dousset, A. Perez, and B. Pitt Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators Circulation 102 2000 2700 2706
29. S.V. Babu-Narayan, A. Uebing, and P.A. Davlouros Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation The APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot) Int J Cardiol 154 2012 299 305